Source link : https://www.newshealth.biz/health-news/semaglutide-may-help-smokers-quit-study-suggests/
Among patients with type 2 diabetes and tobacco use disorder (TUD), use of the GLP-1 receptor agonist semaglutide (Ozempic, Wegovy) was associated with a reduced risk of medical encounters for TUD compared with other diabetes medications, according to an emulation target trial. Using a nationwide population-based database of electronic health records, the strongest association with […]
Author : News Health
Publish date : 2024-07-30 20:17:31
Copyright for syndicated content belongs to the linked Source.
Categories